Altamira’s polyKRASmut siRNA shown to knock down at least 65-91% of KRAS mutations in colorectal, non-small cell lung, and pancreatic cancer cell lines Fresh experimental data expected to strengthen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback